Management of sleeve gastrectomy leakage with endoscopic stenting

Background: Sleeve gastrectomy is one of the most commonly applied procedures for obesity surgery. Leakage from the stapler line and bleeding are the most important complications of sleeve gastrectomy. This study aimed to report the results of esophageal stent procedure applied to cases who developed leaks after sleeve gastrectomy.Methods: This study included patients who had sleeve gastrectomy due to morbid obesity and were detected to have a leak after the procedure. Demographic features, time of leakage after the surgery, and the management of the leak were analyzed.Results: it was detected in this study, 1220 cases who had sleeve gastrectomy for morbid obesity. Leaks were developed in 10 patients after Laparoscopic Sleeve Gastrectomy (LSG). Four patients, followed conservatively without stent application, were excluded. Six patients, treated with stent application, were included. Two of the patients were males, and four were females (M/F=1/2). The mean age was 38.3 (±11.57) (range: 26-58). The mean body mass index was 43.26 (±2.10)kg/m2. The incidence of a leak was 0.81%.Conclusions: In a conclusion, stents can be safely applied by experienced endoscopists for the management of sleeve gastrectomy leakage.

Download Full-text

Risk of Asymptomatic Gallstones Becoming Symptomatic After Laparoscopic Sleeve Gastrectomy

The American Surgeon ◽

10.1177/00031348211011107 ◽

2021 ◽

pp. 000313482110111

Author(s):

Ozan Şen ◽

Ahmet G. Türkçapar

Keyword(s):

Body Mass Index ◽

Sleeve Gastrectomy ◽

Retrospective Study ◽

Laparoscopic Sleeve Gastrectomy ◽

Abdominal Ultrasound ◽

Concomitant Cholecystectomy ◽

Study Population ◽

The Mean ◽

Asymptomatic Gallstones

Background Whether concomitant cholecystectomy is needed during laparoscopic sleeve gastrectomy (LSG) in patients with asymptomatic cholelithiasis is controversial. In this study, our aim is to show the follow-up results in patients with asymptomatic cholelithiasis who underwent LSG alone. Methods Patients undergoing primary LSG between March 2018 and September 2020 with asymptomatic gallbladder stones were included in this retrospective study. All patients underwent abdominal ultrasound (US) before surgery. Patients’ demographics and postoperative outcomes were recorded. Results A total of 180 patients underwent primary LSG and completed the 1-year follow-up. The study population consisted of 42 patients (23%) with asymptomatic cholelithiasis. The mean age was 41.1±7.1 years (31-56, 63% female), and mean body mass index (BMI) was 44 ± 6.7 kg/m2. Average BMI decreased to 31.1 ± 4.7 kg/m2 at 6 months and to 27.3 ± 3.6 kg/m2 at 1 year. The average follow-up period was 17 ± 5.7 months (range, 12-28 months). Of the 42 patients, only 1 patient (2.4%) became symptomatic during the follow-up period. Discussion We do not recommend cholecystectomy in patients with asymptomatic gallstones during the same session with LSG. An observational approach should be adopted for these patients.

Download Full-text

Decision Regret after Laparoscopic Sleeve Gastrectomy—5 Years’ Perspective

Obesity Surgery ◽

10.1007/s11695-021-05480-0 ◽

2021 ◽

Author(s):

Katarzyna Bartosiak ◽

Michał R. Janik ◽

Piotr Kowalewski ◽

Maciej Walędziak ◽

Andrzej Kwiatkowski

Keyword(s):

Body Mass Index ◽

Weight Loss ◽

Sleeve Gastrectomy ◽

Laparoscopic Sleeve Gastrectomy ◽

Body Mass ◽

Negative Correlation ◽

Telephone Survey ◽

Significant Negative Correlation ◽

Decision Regret ◽

The Mean

Abstract Introduction Patient's satisfaction after weight loss surgery is in the research spotlight. However, there are still no quantitative data regarding whether patients regret their decision to undergo laparoscopic sleeve gastrectomy (SG). Objectives The present study aimed to evaluate whether patients regret their decision to undergo SG 5 years after surgery. The secondary objective was to identify whether weight loss and a higher quality of life (QoL) score correlate with the regret expressed by patients. Setting Military Hospital, Poland Methods A telephone survey was carried out among patients 5 years after surgery. Patient satisfaction regarding their decision to undergo SG was assessed using the Decision Regret Scale. QoL scores were determined using the 36-Item Short Form Survey (SF-36). Results One hundred and four patients who answered a full telephone survey were enrolled in the study. Change in body mass index (ΔBMI) was 12.31±6.2, excess body mass index loss (%EBMIL) was 55.45%±25.52%, and percent total weight loss (%TWL) was 25.20%±11.7%. At the 5-year postoperative telephone survey, the mean general health score was 50.96±14.0 and the mean regret score was 32.33±13.24 (range, 25–85). A statistically significant negative correlation was observed between %EBMIL and regret score (r=−0.435; p<0.001). There was a significant negative association between regret score and energy/fatigue QoL (r=−0.205; p=0.040). Only eight patients (7.69%) scored >50 on the Decision Regret Scale, which was considered to represent overall regret for their decision. Conclusion Our study suggests that, in general, patients did not regret their decision to undergo SG. Key Points The majority of patients did not regret their decision to undergo SG. There was a statistically significant negative correlation between weight loss and patients’ feelings of regret. Energy/fatigue QoL was the strongest correlate of whether patients regretted their decision to undergo SG. Graphical Abstract

Download Full-text

The impact of preoperative body mass index on early complications post laparoscopic sleeve gastrectomy for morbid obesity

Zagazig University Medical Journal ◽

10.21608/zumj.2019.11201.1173 ◽

2019 ◽

Vol 0 (0) ◽

pp. 0-0

Author(s):

Mustafa Eljadal ◽

Ali El-Shewy ◽

tamer alnaimy ◽

walid aidaros

Keyword(s):

Body Mass Index ◽

Morbid Obesity ◽

Sleeve Gastrectomy ◽

Laparoscopic Sleeve Gastrectomy ◽

Body Mass ◽

Early Complications ◽

Preoperative Body Mass Index ◽

The Impact

Download Full-text

Impact of preoperative body mass index on the final outcome after laparoscopic sleeve gastrectomy for morbid obesity

Turkish Journal of Surgery ◽

10.5152/ucd.2016.3275 ◽

2016 ◽

Vol 32 (4) ◽

pp. 238-243 ◽

Cited By ~ 7

Author(s):

Hosam Elbanna ◽

Wagih Ghnnam ◽

Ahmed Negm ◽

Tamer Youssef ◽

Sameh Emile ◽

...

Keyword(s):

Body Mass Index ◽

Morbid Obesity ◽

Sleeve Gastrectomy ◽

Laparoscopic Sleeve Gastrectomy ◽

Body Mass ◽

Final Outcome ◽

Preoperative Body Mass Index

Download Full-text

Laparoscopic Sleeve Gastrectomy Versus Laparoscopicmini-Gastric Bypass in Management of Morbid Obesity and its Comorbidities

Indian Journal of Public Health Research & Development ◽

10.37506/v11/i2/2020/ijphrd/195237 ◽

2020 ◽

Vol 11 (2) ◽

pp. 2572

Author(s):

Tantawi Abdel Naeem Mohamed ◽

Salah Abdel- Razik ◽

Ayman Mohamed Hassanien ◽

Tohamy A. Tohamy ◽

Ashraf Abdel Azeem ◽

...

Keyword(s):

Morbid Obesity ◽

Gastric Bypass ◽

Sleeve Gastrectomy ◽

Laparoscopic Sleeve Gastrectomy

Download Full-text

Efficacy of laparoscopic sleeve gastrectomy for patient with morbid obesity and type 1 diabetes mellitus: a case report

Surgical Case Reports ◽

10.1186/s40792-020-00989-5 ◽

2021 ◽

Vol 7 (1) ◽

Author(s):

Hidetaka Ichikawa ◽

Hirofumi Imoto ◽

Naoki Tanaka ◽

Hiroaki Musha ◽

Shojiro Sawada ◽

...

Keyword(s):

Diabetes Mellitus ◽

Bariatric Surgery ◽

Morbid Obesity ◽

Body Weight ◽

Sleeve Gastrectomy ◽

Laparoscopic Sleeve Gastrectomy ◽

Hba1c Level ◽

Insulin Dose ◽

Body Weight Loss

Abstract Background Bariatric surgery is effective for the treatment of patients with morbid obesity and type 2 diabetes mellitus (T2DM), for body weight loss and glycemic control. However, in Japan, there has been no previous report of the effectiveness bariatric surgery in a case of morbid obesity associated with acute onset type 1 diabetes mellitus (T1DM), in which pancreatic β-cells were destroyed and endogenous insulin was depleted. Case presentation A 36-year-old woman with morbid obesity and T1DM, diagnosed when she was 6 years, was admitted for bariatric surgery. At her first consultation, she had a body weight of 106.7 kg and a body mass index of 42.2 kg/m2. Her HbA1c level was 9.0%, with a required daily insulin dose of 75 units. She underwent laparoscopic sleeve gastrectomy. At 1 year after surgery, her body weight had decreased to 81.0 kg and her body mass index to 32.2 kg/m2. In addition, her daily required dose of insulin had decreased to 24 units, with an improvement in her HbA1c level to 7.7%. Conclusions Although further evidence needs to be accumulated, including long-term outcomes, laparoscopic sleeve gastrectomy may provide an effective treatment for patients with morbid obesity and T1DM for body weight loss, improvement in HbA1c level, and insulin dose reduction.

Download Full-text

Five-year Outcomes of Sleeve Gastrectomy: A Prospective Multicenter study

The American Surgeon ◽

10.1177/0003134821991984 ◽

2021 ◽

pp. 000313482199198

Author(s):

Imad El Moussaoui ◽

Etienne Van Vyve ◽

Hubert Johanet ◽

André Dabrowski ◽

Arnaud Piquard ◽

...

Keyword(s):

Body Mass Index ◽

Weight Loss ◽

Sleeve Gastrectomy ◽

Body Mass ◽

Excess Weight Loss ◽

Prospective Multicenter Study ◽

Weight Loss Failure ◽

Obstructive Sleep ◽

The Mean ◽

Predictors Of Weight Loss

Background Sleeve gastrectomy (SG) is the most frequently performed bariatric procedure in the world. Our purpose was to evaluate the percentage of excess weight loss (%EWL), resolution of obesity-related comorbidities after SG, and identify predictive factors of weight loss failure. Methods A prospective cohort study of adults who underwent SG during 2014 in 7 Belgian-French centers. Their demographic, preoperative, and postoperative data were prospectively collected and analyzed statistically. Results Overall, 529 patients underwent SG, with a mean preoperative weight and body mass index (BMI) of 118.9 ± 19.9 kg and 42.9 ± 5.5 kg/m2, respectively. Body mass index significantly decreased to 32.2 kg/m2 at 5 years ( P < .001). The mean %EWL was 63.6% at 5 years. A significant reduction in dyslipidemia (28.0%-18.2%), obstructive sleep apnea (OSAS) (34.6%-25.1%), and arterial hypertension (HTN) (30.4%-21.5%) was observed after 5 years, but not for diabetes and gastroesophageal reflux disease (GERD). At multivariate analysis, age >50 years old, BMI >50 kg/m2, and previous laparoscopic adjustable gastric banding (LAGB) remained independent predictors of weight loss failure. Conclusions Five years after SG, weight loss was satisfactory; the reduction of comorbidities was significant for dyslipidemia, OSAS, and HTN, but not diabetes and GERD. Age >50 years old, BMI >50 kg/m2, and previous LAGB were independent predictors of weight loss failure.

Download Full-text